GE Healthymagination, part of GE Ventures, led the D round as a new investor
Labcyte, a US-based company advancing acoustic liquid handling, has raised $5.3m in its series D round led by industrial conglomerate General Electric’s (GE) healthcare-focused corporate venturing fund.
GE Healthymagination, part of GE Ventures, led the D round as a new investor, with participation from venture capital firms Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors and H&Q Life Sciences Investors.
Labcyte will use the investment to continue to expand its liquid handling systems based on the use…
